Budgetary Impact Analysis of Reimbursement Varenicline for the Smoking-Cessation Treatment in Patients with Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease or Type-2 Diabetes Mellitus: A National Health System Perspective

By  

European Addiction Research, Vol. 23, Iss. 1, 2016-10 ,pp. : 7-18

Karger

Access to resources Recommend Favorite

Saxagliptin for the treatment of type 2 diabetes mellitus: Focus on recent studies

By Schwartz Sherwyn L.  

Annals of Medicine, Vol. 44, Iss. 2, 2012-03 ,pp. : 157-169

Informa Healthcare

Access to resources Recommend Favorite

Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes

By Rosenstock J.   Aguilar-Salinas C.   Klein E.   Nepal S.   List J.   Chen R.    

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2401-2411

Informa Healthcare

Access to resources Recommend Favorite

Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care

By Mata-Cases Manel   Benito-Badorrey Belén   Roura-Olmeda Pilar   Franch-Nadal Josep   Pepió-Vilaubí Josep Maria   Saez Marc   Coll-de-Tuero Gabriel    

Current Medical Research and Opinion, Vol. 29, Iss. 11, 2013-11 ,pp. : 1495-1502

Informa Healthcare

Access to resources Recommend Favorite

Keeping the right track in the treatment of patients with type 2 diabetes

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 20, Iss. 1, 2018-01 ,pp. : 52-54

John Wiley & Sons Inc

Access to resources Recommend Favorite